ClinicalTrials.govpublic full text
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
locally advanced unresectable gastroesophageal junction (gej) adenocarcinoma or cancer, locally advanced unresectable gastric adenocarcinoma or cancer, metastatic gastric adenocarcinoma or cancer, metastatic gastroesophageal junction (gej) adenocarcinoma, locally advanced unresectable gastroesophageal junction (gej) adenocarcinoma cancer, locally advanced unresectable gastric adenocarcinoma cancer, metastatic gastric adenocarcinoma cancer, claudin 18.2, pd-l1, human epidermal growth factor receptor 2 (her2) negative, zolbetuximab, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 891422
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.